https://scholars.lib.ntu.edu.tw/handle/123456789/161418
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor | 臺大醫院;臺大醫院-腫瘤醫學部;臺大醫院-醫學研究部;臺大醫學院-腫瘤醫學研究所;臺大醫學院-臨床醫學研究所; | - |
dc.contributor.author | Tan, Daniel Shao-Weng | en |
dc.contributor.author | Seto, Takashi | en |
dc.contributor.author | Leighl, Natasha B. | en |
dc.contributor.author | Riely, Gregory J. | en |
dc.contributor.author | Sequist, Lecia V. | en |
dc.contributor.author | Felip, Enriqueta | en |
dc.contributor.author | Wolf, Juergen | en |
dc.contributor.author | Yang, James Chih-Hsin | en |
dc.contributor.author | Matushansky, Igor | en |
dc.contributor.author | Yu, Xiaolu | en |
dc.contributor.author | Schmitz, Shu-Fang Hsu | en |
dc.contributor.author | Cui, Xiaoming | en |
dc.contributor.author | Kim, Dong-Wan | en |
dc.creator | Tan, Daniel Shao-Weng;Seto, Takashi;Leighl, Natasha B.;Riely, Gregory J.;Sequist, Lecia V.;Felip, Enriqueta;Wolf, Juergen;Yang, James Chih-Hsin;Matushansky, Igor;Yu, Xiaolu;Schmitz, Shu-Fang Hsu;Cui, Xiaoming;Kim, Dong-Wan | en |
dc.creator | 楊志新 | zh-tw |
dc.date | 2015 | - |
dc.date.accessioned | 2017-06-22T07:59:44Z | - |
dc.date.accessioned | 2018-07-09T02:39:42Z | - |
dc.date.available | 2017-06-22T07:59:44Z | - |
dc.date.available | 2018-07-09T02:39:42Z | - |
dc.date.issued | 2015 | - |
dc.identifier.uri | http://ntur.lib.ntu.edu.tw//handle/246246/279801 | - |
dc.language | en-us | - |
dc.relation | J. Clin. Oncol., 33(15), | - |
dc.relation.ispartof | J. Clin. Oncol. | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.title | First-in-human phase I study of EGF816, a third generation, mutant-selective EGFR tyrosine kinase inhibitor, in advanced non-small cell lung cancer (NSCLC) harboring T790M. | - |
dc.relation.pages | - | - |
dc.relation.journalvolume | 33 | - |
dc.relation.journalissue | 15 | - |
item.grantfulltext | none | - |
item.fulltext | no fulltext | - |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。